patient | CD34 reactivity | CD99 reactivity | BCL2 reactivity | Vimentin (V9) reactivity | actin HHF35 | smooth muscle actin | desmin | S100 | keratin | MNF116 | EMA | MiB1 | necrosis | average mitoses/10 HPF | malignant component | additional tests |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | focal positive | focal positive | positive | positive | - | - | - | - | - | - | - | - | absent | <4 | absent | Â |
2 | focal positive | - | - | positive | - | focal positive | - | negative | negative | - | - | 1% | absent | <4 | absent | Â |
3 | positive | positive | - | positive | focal positive | focal positive | focal positive | negative | negative | - | - | 5% | absent | <4 | Â | loss on chromosome 13q |
4 | focal positive | focal positive | focal positive | focal positive | - | focal positive | focal positive | - | negative | negative | - | 1–2% | absent | <1 | absent |  |
5 | positive | positive | - | positive | - | - | - | negative | negative | - | negative | 5–10% | present | 10 | present | HMB 45 negative |
6 | focal positive | positive | positive | positive | negative | negative | negative | negative | negative | negative | focal positive | <5% | absent | <4 | absent | Keratin AE1/AE3 negative |
7 | positive | positive | positive | positive | - | - | - | - | - | - | focal positive | <1% | absent | <4 | absent | Â |
8 | positive | positive | positive | positive | - | - | negative | negative | negative | negative | negative | 5% | present | 3 | present | HMB 45 negative Keratin AE1/AE3 focal |
9 | positive | positive | positive | focal positive | negative | negative | - | - | - | - | - | 5–10% | absent | <4 | absent |  |